Related Experiment Videos

Disruption of the aortic anastomosis after heart-lung transplantation

R D Dowling1, N Baladi, M Zenati

  • 1Department of Surgery, University of Pittsburgh, Pennsylvania 15261.

Insights

Candida species in donor lungs can cause fatal aortic disruption after heart-lung transplants. Prophylactic amphotericin B and omental wrapping are now used to prevent this fungal infection.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Transplant Surgery

Background:

  • Heart-lung transplantation is a life-saving procedure for end-stage cardiopulmonary disease.
  • Anastomotic site complications, including aortic disruption, can occur post-transplant.
  • Fungal infections, particularly Candida species, pose a significant threat in immunocompromised patients.

Observation:

  • Four of 66 heart-lung transplant recipients experienced aortic disruption at the anastomotic site, all resulting in mortality.
  • Candida species were implicated in three cases, with fungal presence noted on suture lines or in aortic walls.
  • Donor trachea cultures revealed Candida in two of these three patients, suggesting transmission.

Findings:

  • Donor-derived Candida infection is a significant risk factor for fatal aortic anastomotic disruption post-heart-lung transplant.
  • Complications included massive hemorrhage, right ventricular outflow tract obstruction, and pseudoaneurysm formation.
  • Previous antifungal treatments were unsuccessful, highlighting the need for new preventive strategies.

Implications:

  • A high index of suspicion for Candida in donor lungs is crucial for heart-lung transplant recipients.
  • Prophylactic amphotericin B is now part of the regimen to prevent invasive fungal infections.
  • Omental wrapping of the trachea and aorta may reduce mediastinal infection spread to the aortic suture line.

Related Concept Videos